Melanocortin-4 receptor gene mutations in obese Slovak children

D Stanikova1, M Surova, L Ticha

  • 1DIABGENE Laboratory, Institute of Experimental Endocrinology, Slovak Academy of Sciences, Bratislava, Slovakia. daniela.gasperikova@savba.sk.

Insights

Mutations in the Melanocortin-4 receptor (MC4R) gene are a common cause of monogenic obesity. In Slovak obese children, MC4R loss-of-function variants were found at a low prevalence of 0.7%.

Area of Science:

  • Genetics
  • Pediatrics
  • Endocrinology

Background:

  • Non-syndromic monogenic obesity frequently results from mutations in the Melanocortin-4 receptor (MC4R) gene.
  • MC4R mutation prevalence varies significantly across different countries, ranging from 1.2% to 6.3% in obese children.

Purpose of the Study:

  • To investigate the prevalence of MC4R mutations in obese children in Slovakia.
  • To compare these findings with prevalence rates in other European populations.
  • To characterize the phenotype of MC4R mutation carriers.

Main Methods:

  • DNA analysis using direct Sanger sequencing of MC4R coding exons and intron/exon boundaries.
  • Study included 268 unrelated Slovak children and adolescents with obesity (BMI > 97th percentile) and early onset (mean age 4.3 years).

Main Results:

  • Two previously described heterozygous loss-of-function MC4R variants (p.Ser19Alafs*34, p.Ser127Leu) were identified in two obese probands.
  • One obese and one lean adult family relative carried the p.Ser127Leu variant.
  • No loss-of-function variants were detected in lean control individuals.
  • The prevalence of MC4R loss-of-function variants in obese Slovak children was 0.7%, one of the lowest reported in Europe.

Conclusions:

  • The prevalence of MC4R loss-of-function variants in obese Slovak children is low compared to other European populations.
  • This study contributes to understanding the geographical variation in MC4R mutation frequencies related to monogenic obesity.

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.6K
Lethal Alleles02:41

Lethal Alleles

Agouti: A Lethal Allele
Lucien Cuénot discovered lethal alleles in 1905 while studying the inheritance of coat color in mice. The agouti gene is responsible for the color of the coat in mice. This gene codes for an agouti-signaling protein, which is responsible for melanin distribution in mammals. The wild-type allele gives rise to gray-brown coat color in mice, while the mutant allele gives rise to yellow coat color. In addition to coat color, the agouti gene is associated with the yellow...
19.9K
Human Genetics01:28

Human Genetics

Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
1.9K
Incomplete Dominance01:43

Incomplete Dominance

Gregor Mendel's work (1822 - 1884) was primarily focused on pea plants. Through his initial experiments, he determined that every gene in a diploid cell has two variants called alleles inherited from each parent. He suggested that amongst these two alleles, one allele is dominant in character and the other recessive. The combination of alleles determines the phenotype of a gene in an organism.
32.8K
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
69
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
303